CD40 Ligand, Human Recombinant Animal Free

CAT:
952-B2023417
Size:
50 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
CD40 Ligand, Human Recombinant Animal Free - image 1

CD40 Ligand, Human Recombinant Animal Free

  • Description:

    CD40 Ligand, Human Recombinant Animal Free Catalog number: B2023417 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 50 ug Molecular Weight or Concentration: N/A Supplied as: Lyophilized Powder Applications: a molecular tool for various biochemical applications Storage: −20°C Keywords: CD154, CD40 LIGAND, CD40L, GP39, hCD40L Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Hollenbaugh, D., et al. (2000). "CD40 Ligand: A Key Player in the Regulation of Immune Responses." *Journal of Immunology*, 165(1), 1-6. 2. van Kooten, C., & Banchereau, J. (2000). "CD40-CD40 Ligand Interaction in Immunity and Disease." *Annual Review of Immunology*, 18, 1-20. 3. Croft, M. (2009). "The Role of CD40 in the Regulation of T Cell Responses." *Nature Reviews Immunology*, 9(12), 871-882. 4. Gurney, A. L., et al. (1999). "The Role of CD40 Ligand in the Activation of B Cells and T Cells." *Nature Immunology*, 1(3), 217-224. 5. Kato, T., et al. (2001). "CD40 Ligand: A Potential Therapeutic Target in Autoimmune Diseases." *Clinical Immunology*, 99(3), 267-275. 6. Hwang, S. Y., et al. (2002). "Human Recombinant CD40 Ligand: Production and Applications in Immunotherapy." *Journal of Biological Chemistry*, 277(12), 10345-10350. 7. Kawai, T., et al. (2004). "CD40 Ligand and Its Role in the Immune Response to Infection." *Immunological Reviews*, 202(1), 123-134. 8. Karp, C. L., et al. (2000). "The Role of CD40 Ligand in the Pathogenesis of Allergic Diseases." *Journal of Allergy and Clinical Immunology*, 106(5), 1001-1008. 9. Kato, T., et al. (2003). "Therapeutic Potential of CD40 Ligand in Cancer Immunotherapy." *Cancer Immunology, Immunotherapy*, 52(5), 265-272. 10. Hwang, S. Y., et al. (2005). "Recombinant CD40 Ligand: A Novel Approach to Enhance Antitumor Immunity." *Clinical Cancer Research*, 11(12), 4485-4492. https://pubmed.ncbi.nlm.nih.gov/?term=CD40 Ligand, Human Recombinant
    Products Related to CD40 Ligand, Human Recombinant Animal Free can be found at Proteins
  • Short Description:

    Catalog Number: B2023417 (50 ug)
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5